Understanding muscle problems in myotonic dystrophy type 1
Mechanisms of Skeletal Muscle Pathogenesis in Myotonic Dystrophy Type 1
This study is looking at how certain genetic changes in people with myotonic dystrophy type 1 can cause muscle weakness and wasting, and it aims to find new ways to help manage these issues by understanding how specific RNA molecules affect muscle function.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11075579 on NIH RePORTER |
What this research studies
This research investigates the underlying mechanisms that lead to muscle weakness and wasting in individuals with myotonic dystrophy type 1 (DM1). The study focuses on how specific RNA molecules, which are produced due to genetic mutations, disrupt normal muscle function by affecting the regulation of important proteins involved in muscle development. By using mouse models, researchers aim to uncover the processes that cause these disruptions, which could lead to new therapeutic strategies for managing the disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with myotonic dystrophy type 1, particularly those experiencing muscle weakness.
Not a fit: Patients with other forms of muscular dystrophy or unrelated muscle disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for muscle weakness in patients with myotonic dystrophy type 1.
How similar studies have performed: Previous research has shown promising results in understanding muscle pathogenesis in similar genetic disorders, indicating that this approach has potential for success.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Cooper, Thomas a — Baylor College of Medicine
- Study coordinator: Cooper, Thomas a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.